,datetime,sentence,positive,negative,neutral,global_sentiment,avg_sentiment
0,2014-10-20 04:05:00,"Medical device major Boston Scientific Corporation ( BSX ) recently launched its Accolade family of pacemakers in the European market, after winning the CE (Conformité Européenne) Mark approval for the same.",0.9276489615440369,0.015417930670082569,0.0569331981241703,positive,0.9122310280799866
1,2014-10-20 04:05:00,This latest family of pacemakers provides the best pacing therapies to heart patients while offering them unprecedented access to full-body imaging.,0.8560789227485657,0.013889915309846401,0.13003110885620117,positive,0.8421890139579773
2,2014-10-20 04:05:00,"However, following the news, Boston Scientific's shares slipped 0.7% to close at $11.37 on Friday.",0.01722550019621849,0.9707861542701721,0.011988328769803047,negative,-0.9535606503486633
3,2014-10-20 04:05:00,"Boston Scientific's Accolade pacemakers represent the first set of pacing devices which allow patients to receive full-body MRI scans in both 1.5 Tesla and 3.0 Tesla systems, once implanted with the Ingevity leads.",0.24207018315792084,0.006920665502548218,0.7510091662406921,neutral,0.23514951765537262
4,2014-10-20 04:05:00,"Per Prof. Francesco Romeo, who conducted the first Accolade device implant, the complete set of diagnostics and the outstanding longevity this pacemaker provides, will allow physicians to use this device in patients for several years from the time of implantation.",0.42862942814826965,0.008078859187662601,0.5632916688919067,neutral,0.42055055499076843
5,2014-10-20 04:05:00,"Currently, Boston Scientific's ImageReady technology comes in a pack with the Accolade family of pacemakers.",0.125695139169693,0.00587780587375164,0.8684270977973938,neutral,0.1198173314332962
6,2014-10-20 04:05:00,This technology provides the most flexible MRI choices enabling increased energy scan sequences.,0.4655441343784332,0.01041171234101057,0.5240442156791687,neutral,0.4551324248313904
7,2014-10-20 04:05:00,"Additionally, it also features a programmable MRI timer that enhances patient workflow.",0.20990248024463654,0.006979274097830057,0.7831183075904846,neutral,0.20292320847511292
8,2014-10-20 04:05:00,"Per management, this new-age long-lasting Accolade pacemaker facilitated with automatic daily monitoring and advanced diagnostics will help physicians in early diagnosis of atrial fibrillation, which in turn will reduce the risk of stroke in heart patients.",0.8217839598655701,0.014475995674729347,0.16374005377292633,positive,0.8073079586029053
9,2014-10-20 04:05:00,This in turn will not only reduce the rate of patient mortality on account of stroke but will also help curtail overall healthcare costs.,0.9002385139465332,0.01941266842186451,0.08034879714250565,positive,0.8808258175849915
10,2014-10-20 04:05:00,"Evidently, the company's wide range of differentiated portfolio - apart from delivering unique clinical benefits to patients and physicians - also provides economic savings for its customers.",0.9104160666465759,0.013816089369356632,0.07576782256364822,positive,0.8965999484062195
11,2014-10-20 04:05:00,"Recently, the company also won CE Mark approval for its Visionist and Valtitude CRT-Ps equipped with the quadripolar pacing technology.",0.9420835971832275,0.01732652261853218,0.0405898354947567,positive,0.9247570633888245
12,2014-10-20 04:05:00,"Per management, coupled with the Acuity X4 pacing leads, these systems have the ability to pace the target location in one's left ventricle.",0.14492735266685486,0.007613944821059704,0.8474587202072144,neutral,0.13731341063976288
13,2014-10-20 04:05:00,"This, in turn, results in upgrading a patient's response to CRT therapy.",0.6830797791481018,0.013992800377309322,0.3029274046421051,positive,0.6690869927406311
14,2014-10-20 04:05:00,"Currently, the company is actively pursuing MRI compatibility for its existing implantable cardioverter defibrillators (ICD), cardiac resynchronization therapy defibrillators (CRT-D), including the Autogen, Dynagen, Inogen, and Origen CRT-Ds, and lead technologies such as the Ingevity, Reliance and Acuity leads.",0.35203757882118225,0.006890727207064629,0.6410717368125916,neutral,0.34514686465263367
15,2014-10-20 04:05:00,We believe Boston Scientific's continuous attempts to introduce innovative pacing devices for heart patients will help the company gain further profitable share in the expanding cardiac rhythm management (CRM) market.,0.9465606808662415,0.01497331541031599,0.03846611827611923,positive,0.9315873384475708
16,2014-10-20 04:05:00,"Currently, Boston Scientific carries a Zacks Rank #3 (Hold).",0.018744926899671555,0.01581064611673355,0.9654444456100464,neutral,0.0029342807829380035
17,2014-10-20 04:05:00,"Better-ranked stocks in the medical products industry include GW Pharmaceuticals plc ( GWPH ), ZELTIQ Aesthetics, Inc. ( ZLTQ ) and Abaxis, Inc. ( ABAX ).",0.7409375309944153,0.026568962261080742,0.23249344527721405,positive,0.7143685817718506
18,2014-10-20 04:05:00,"While GW Pharmaceuticals and ZELTIQ Aesthetics sport a Zacks Rank #1 (Strong Buy), Abaxis holds a Zacks Rank #2 (Buy).",0.5075146555900574,0.04001079872250557,0.45247456431388855,positive,0.4675038456916809
19,2014-10-20 04:05:00,Want the latest recommendations from Zacks Investment Research?,0.03539300337433815,0.011573811061680317,0.9530332088470459,neutral,0.023819193243980408
20,2014-10-20 04:05:00,"Today, you can download 7 Best Stocks for the Next 30 Days.",0.05069374665617943,0.007019795011729002,0.9422864317893982,neutral,0.04367395117878914
21,2014-10-20 04:05:00,"Click to get this free report

To read this article on Zacks.com click here.",0.02068457007408142,0.033159855753183365,0.9461556077003479,neutral,-0.012475285679101944
22,2014-10-20 04:05:00,"The views and opinions expressed herein are the views and opinions of the author and do not necessarily reflect those of Nasdaq, Inc.",0.010204566642642021,0.01563790813088417,0.9741575717926025,neutral,-0.005433341488242149
